Physician profile
Stanley K Mathis
NPI 1871516922
$2,553.45
in general payments reported to CMS, 2019-2025
24 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2020: $375 · 2021: $135 · 2022: $337 · 2023: $145 · 2024: $268 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,300.73 | 2019-2024 | Stravix, Collagenase Santyl, Grafix Pl |
| Biotissue Holdings INC. | $326.78 | 2021-2025 | |
| Stryker Corporation | $150.76 | 2022-2025 | Valor |
| Integra Lifesciences Corporation | $122.64 | 2019-2022 | |
| Paragon 28, INC. | $100.34 | 2019-2022 | |
| Misonix INC | $66.80 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $53.22 | 2019 | |
| Medline Industries LP | $49.10 | 2019 | |
| Kci USA, INC. | $48.15 | 2019-2020 | |
| Allergan, INC. | $45.44 | 2019 | |
| Aroa Biosurgery Incorporated | $34.87 | 2023-2024 | |
| Hartmann USA, INC. | $28.85 | 2022 | |
| Organogenesis INC. | $28.56 | 2019 | |
| Abbvie INC. | $27.52 | 2023 | |
| Tenex Health INC. | $25.34 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $24.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Polarityte, INC. | $23.98 | 2019 | |
| Hikma Pharmaceuticals USA | $19.70 | 2022 | |
| Bone Support INC. | $17.39 | 2024 | Cerament G, Ceramentbone Void Filler |
| Celularity INC. | $17.00 | 2019 | |
| Vertiflex, INC. | $16.11 | 2019 | |
| Djo, LLC | $13.74 | 2023 | Donjoy, Aircast |
| Osiris Therapeutics INC. | $12.36 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.